Member
|
|
Join Date: Feb 2014
Posts: 365
|
|
Member
Join Date: Feb 2014
Posts: 365
|
Michael Fox and Partners plan to Start Nilotinib Study in 2017
Quote:
Originally Posted by Betsy859
My last appointment at Georgetown Medstar movement disorder clinic I got some Information about the second phase of the Nilotinib trial. It's scheduled to start this summer and has funding. The funding is coming from foundations not Novartis. However Novartis is being approached to give the medications used in the trial. At the present time the trial will be testing the drug on stage l and stage ll PDers. It involves a lot of planning so my neuro said it could be delayed but he emphasized the funding was there. I don't know anything about the placebo group and how that will be handled. I go back again in March and he said he would give me all the current information he has on the trial at that time.
This is all I have at this time but will keep you posted about any information I'm told at my appointments. I'll ask about the placebo groups next visit.
|
Michael Fox and Partners plan to Start Nilotinib Study in 2017!
Parkinson's Disease | Nilotinib Update: Where We Stand with a Cancer Drug for Parkinson’s
|